Mercury Alters B-Cell Protein Phosphorylation Profiles-Reference-Cited by-同舟云学术

Mercury Alters B-Cell Protein Phosphorylation Profiles

Published:2013-12-04 Issue:2 Volume:13 Page:496-505
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Caruthers Nicholas J.¹,Stemmer Paul M.¹,Shin Namhee¹,Dombkowski Alan¹,Caruso Joseph A.¹,Gill Randal¹,Rosenspire Allen¹

Affiliation:

1. Institute of Environmental Health Sciences, ‡Department of Pediatrics, and §Department of Immunology and Microbiology, Wayne State University, Detroit, Michigan 48201, United States

Publisher

American Chemical Society (ACS)

Subject

General Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/pr400657k

Reference53 articles.

1. Review: Environmental exposure to mercury and its toxicopathologic implications for public health

2. Review: Environmental exposure to mercury and its toxicopathologic implications for public health

3. Clinical toxicology of mercury

4. The Toxicology of Mercury

5. Organic mercury compounds: human exposure and its relevance to public health

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. At low levels, inorganic mercury interference with antigen signaling is associated with modifications to a panel of novel phosphoserine sites in B cell receptor pathway proteins;Toxicology in Vitro;2023-06

2. Mercury-induced autoimmunity: Report of two adolescent siblings with Morvan syndrome “plus” and review of the literature;Journal of Neuroimmunology;2020-05

3. Developmental exposure to mercury chloride impairs social behavior in male offspring dependent on genetic background and maternal autoimmune environment;Toxicology and Applied Pharmacology;2019-05

4. Low level Hg 2+ exposure modulates the B-cell cytoskeletal phosphoproteome;Journal of Proteomics;2018-02

5. Phosphoproteome and transcription factor activity profiling identify actions of the anti-inflammatory agent UTL-5g in LPS stimulated RAW 264.7 cells including disrupting actin remodeling and STAT-3 activation;European Journal of Pharmacology;2017-09